US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 5.620
  • +0.010+0.18%
Trading Apr 18 09:33 ET
462.16MMarket Cap-2782P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
296.32%78.12M
818.74%60.05M
12,604.76%5.34M
-54.62%2.89M
45.49%9.85M
-22.83%19.71M
-47.58%6.54M
-99.32%42K
1,578.63%6.36M
4.19%6.77M
Operating revenue
296.32%78.12M
818.74%60.05M
12,604.76%5.34M
-54.62%2.89M
45.49%9.85M
-22.83%19.71M
-47.58%6.54M
-99.32%42K
1,578.63%6.36M
4.19%6.77M
Cost of revenue
Gross profit
Operating expense
0.67%247.3M
20.05%84.01M
-3.58%55.5M
-22.47%46.98M
5.72%60.81M
12.33%245.66M
29.41%69.98M
26.65%57.56M
8.63%60.6M
-9.25%57.52M
Selling and administrative expenses
-1.49%69.65M
-19.62%14.46M
-7.69%14.99M
1.56%17.2M
17.72%23.01M
-7.19%70.7M
8.82%17.98M
0.32%16.24M
-23.11%16.94M
-8.86%19.55M
-General and administrative expense
-1.49%69.65M
-19.62%14.46M
-7.69%14.99M
1.56%17.2M
17.72%23.01M
-7.19%70.7M
8.82%17.98M
0.32%16.24M
-23.11%16.94M
-8.86%19.55M
Research and development costs
1.54%177.65M
33.77%69.56M
-1.97%40.51M
-31.79%29.78M
-0.45%37.8M
22.77%174.96M
38.47%52M
41.21%41.33M
29.35%43.66M
-9.45%37.98M
Operating profit
25.12%-169.18M
62.23%-23.96M
12.79%-50.16M
18.70%-44.09M
-0.42%-50.96M
-16.98%-225.95M
-52.48%-63.45M
-46.54%-57.52M
2.11%-54.23M
10.78%-50.75M
Net non-operating interest income expense
218.34%17.57M
88.13%5.1M
186.89%5.14M
597.99%3.81M
648.19%3.51M
809.06%5.52M
1,449.71%2.71M
1,079.61%1.79M
273.97%546K
250.00%469K
Non-operating interest income
218.34%17.57M
88.13%5.1M
186.89%5.14M
597.99%3.81M
----
809.06%5.52M
1,449.71%2.71M
1,079.61%1.79M
273.97%546K
----
Total other finance cost
----
----
----
----
-648.19%-3.51M
----
----
----
----
---469K
Other net income (expense)
-1.6M
-14K
-102.98%-7K
-576.92%-1.58M
-94.74%1K
23,600.00%235K
-1,214.29%-234K
Other non- operating income (expenses)
---1.6M
---14K
----
-102.98%-7K
-576.92%-1.58M
----
----
-94.74%1K
23,600.00%235K
-1,214.29%-234K
Income before tax
30.49%-153.22M
68.93%-18.87M
19.21%-45.02M
24.63%-40.29M
2.93%-49.04M
-14.51%-220.43M
-46.58%-60.74M
-42.59%-55.73M
3.26%-53.45M
10.95%-50.52M
Income tax
Net income
30.49%-153.22M
68.93%-18.87M
19.21%-45.02M
24.63%-40.29M
2.93%-49.04M
-14.51%-220.43M
-46.58%-60.74M
-42.59%-55.73M
3.26%-53.45M
10.95%-50.52M
Net income continuous Operations
30.49%-153.22M
68.93%-18.87M
19.21%-45.02M
24.63%-40.29M
2.93%-49.04M
-14.51%-220.43M
-46.58%-60.74M
-42.59%-55.73M
3.26%-53.45M
10.95%-50.52M
Minority interest income
Net income attributable to the parent company
30.49%-153.22M
68.93%-18.87M
19.21%-45.02M
24.63%-40.29M
2.93%-49.04M
-14.51%-220.43M
-46.58%-60.74M
-42.59%-55.73M
3.26%-53.45M
10.95%-50.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.49%-153.22M
68.93%-18.87M
19.21%-45.02M
24.63%-40.29M
2.93%-49.04M
-14.51%-220.43M
-46.58%-60.74M
-42.59%-55.73M
3.26%-53.45M
10.95%-50.52M
Basic earnings per share
37.07%-2.02
73.86%-0.23
32.10%-0.55
28.21%-0.56
4.05%-0.71
-12.63%-3.21
-44.26%-0.88
-42.11%-0.81
3.70%-0.78
13.95%-0.74
Diluted earnings per share
37.07%-2.02
73.86%-0.23
32.10%-0.55
28.21%-0.56
4.05%-0.71
-12.63%-3.21
-44.26%-0.88
-42.11%-0.81
3.70%-0.78
13.95%-0.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 296.32%78.12M818.74%60.05M12,604.76%5.34M-54.62%2.89M45.49%9.85M-22.83%19.71M-47.58%6.54M-99.32%42K1,578.63%6.36M4.19%6.77M
Operating revenue 296.32%78.12M818.74%60.05M12,604.76%5.34M-54.62%2.89M45.49%9.85M-22.83%19.71M-47.58%6.54M-99.32%42K1,578.63%6.36M4.19%6.77M
Cost of revenue
Gross profit
Operating expense 0.67%247.3M20.05%84.01M-3.58%55.5M-22.47%46.98M5.72%60.81M12.33%245.66M29.41%69.98M26.65%57.56M8.63%60.6M-9.25%57.52M
Selling and administrative expenses -1.49%69.65M-19.62%14.46M-7.69%14.99M1.56%17.2M17.72%23.01M-7.19%70.7M8.82%17.98M0.32%16.24M-23.11%16.94M-8.86%19.55M
-General and administrative expense -1.49%69.65M-19.62%14.46M-7.69%14.99M1.56%17.2M17.72%23.01M-7.19%70.7M8.82%17.98M0.32%16.24M-23.11%16.94M-8.86%19.55M
Research and development costs 1.54%177.65M33.77%69.56M-1.97%40.51M-31.79%29.78M-0.45%37.8M22.77%174.96M38.47%52M41.21%41.33M29.35%43.66M-9.45%37.98M
Operating profit 25.12%-169.18M62.23%-23.96M12.79%-50.16M18.70%-44.09M-0.42%-50.96M-16.98%-225.95M-52.48%-63.45M-46.54%-57.52M2.11%-54.23M10.78%-50.75M
Net non-operating interest income expense 218.34%17.57M88.13%5.1M186.89%5.14M597.99%3.81M648.19%3.51M809.06%5.52M1,449.71%2.71M1,079.61%1.79M273.97%546K250.00%469K
Non-operating interest income 218.34%17.57M88.13%5.1M186.89%5.14M597.99%3.81M----809.06%5.52M1,449.71%2.71M1,079.61%1.79M273.97%546K----
Total other finance cost -----------------648.19%-3.51M-------------------469K
Other net income (expense) -1.6M-14K-102.98%-7K-576.92%-1.58M-94.74%1K23,600.00%235K-1,214.29%-234K
Other non- operating income (expenses) ---1.6M---14K-----102.98%-7K-576.92%-1.58M---------94.74%1K23,600.00%235K-1,214.29%-234K
Income before tax 30.49%-153.22M68.93%-18.87M19.21%-45.02M24.63%-40.29M2.93%-49.04M-14.51%-220.43M-46.58%-60.74M-42.59%-55.73M3.26%-53.45M10.95%-50.52M
Income tax
Net income 30.49%-153.22M68.93%-18.87M19.21%-45.02M24.63%-40.29M2.93%-49.04M-14.51%-220.43M-46.58%-60.74M-42.59%-55.73M3.26%-53.45M10.95%-50.52M
Net income continuous Operations 30.49%-153.22M68.93%-18.87M19.21%-45.02M24.63%-40.29M2.93%-49.04M-14.51%-220.43M-46.58%-60.74M-42.59%-55.73M3.26%-53.45M10.95%-50.52M
Minority interest income
Net income attributable to the parent company 30.49%-153.22M68.93%-18.87M19.21%-45.02M24.63%-40.29M2.93%-49.04M-14.51%-220.43M-46.58%-60.74M-42.59%-55.73M3.26%-53.45M10.95%-50.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.49%-153.22M68.93%-18.87M19.21%-45.02M24.63%-40.29M2.93%-49.04M-14.51%-220.43M-46.58%-60.74M-42.59%-55.73M3.26%-53.45M10.95%-50.52M
Basic earnings per share 37.07%-2.0273.86%-0.2332.10%-0.5528.21%-0.564.05%-0.71-12.63%-3.21-44.26%-0.88-42.11%-0.813.70%-0.7813.95%-0.74
Diluted earnings per share 37.07%-2.0273.86%-0.2332.10%-0.5528.21%-0.564.05%-0.71-12.63%-3.21-44.26%-0.88-42.11%-0.813.70%-0.7813.95%-0.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday-0.71%